We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-33.62%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$172M
AUM Growth
-$95.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$35.3M 20.51%
3,931,818
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$30.9M 17.99%
2,747,433
PRAX icon
3
Praxis Precision Medicines
PRAX
$8.8B
$30M 17.46%
195,955
DYN icon
4
Dyne Therapeutics
DYN
$4.24B
$28.5M 16.6%
2,960,046
KRON
5
DELISTED
Kronos Bio
KRON
$20M 11.63%
2,765,314
ALLO icon
6
Allogene Therapeutics
ALLO
$604M
$16.4M 9.53%
1,798,163
LIAN
7
DELISTED
LianBio American Depositary Shares
LIAN
$8.47M 4.92%
2,282,084
QTTB icon
8
Q32 Bio
QTTB
$452M
$2.34M 1.36%
42,825

Similar funds

Vida Ventures Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Vida Ventures Advisors held 8 positions worth $172M, down 36% from $267M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's ten largest holdings make up 100% of its $172M portfolio in Q1 2022.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q1 2022.
  • Vida Ventures Advisors's portfolio value fell 36% quarter-over-quarter to $172M.

Based on Vida Ventures Advisors's 13F filing for Q1 2022, filed 4 May 2022.